PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Company Overview - PROCEPT BioRobotics Corporation aims to revolutionize BPH treatment globally by providing advanced robotic solutions that enhance patient outcomes and deliver value [3] - The company manufactures the AQUABEAM® and HYDROS™ Robotic Systems, with the HYDROS system being the only AI-powered technology for Aquablation therapy [3] - Aquablation therapy is designed to provide effective, safe, and durable outcomes for men suffering from lower urinary tract symptoms (LUTS) due to BPH, regardless of prostate size, shape, or surgeon experience [3] - BPH affects approximately 40 million men in the United States, highlighting the significant market potential for the company's solutions [3] - PROCEPT BioRobotics has established a robust clinical foundation with over 150 peer-reviewed publications supporting the efficacy and advantages of Aquablation therapy [3] Upcoming Investor Event - The company will host an in-person investor event on April 25, 2025, at the Aria Resort in Las Vegas during the American Urological Association Annual Meeting [1] - The event will feature presentations from the management team and clinical perspectives from various physicians [2] - A live webcast of the event will be available, along with an archived recording accessible for at least 90 days post-event [2]